DocSym
β
Searchsearch
Search
(M82.0*) Osteoporosis in multiple myelomatosis
More details coming soon
NaN% mortality rate associated with the disease osteoporosis in multiple myelomatosis
Diagnosis osteoporosis in multiple myelomatosis is diagnosed Prevalent in Women Only
0
Men receive the diagnosis osteoporosis in multiple myelomatosis
0 (No mortality)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0
Women receive the diagnosis osteoporosis in multiple myelomatosis
0 (No mortality)Died from this diagnosis.
Risk Group for the Disease osteoporosis in multiple myelomatosis - Men and Women aged 0
No Cases of the Disease Osteoporosis in multiple myelomatosis identified in Men
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-95+
No Cases of the Disease Osteoporosis in multiple myelomatosis identified in Men
Disease Features osteoporosis in multiple myelomatosis
Absence or low individual and public risk
Osteoporosis in multiple myelomatosis - what does this mean
Osteoporosis in multiple myelomatosis occurs when bone marrow is replaced by cancerous plasma cells, leading to an imbalance in the normal production of bone-forming cells and bone-degrading cells. this results in weakened bones that are more prone to fractures and breaks.
What happens during the disease - osteoporosis in multiple myelomatosis
Osteoporosis in multiple myeloma is caused by a combination of factors, including the production of abnormal proteins by the cancer cells, the direct destruction of bone by the cancer cells, and the production of cytokines and other substances that can interfere with bone formation. the abnormal proteins produced by the cancer cells can lead to an increased breakdown of bone, resulting in decreased bone density and an increased risk of fractures and other bone-related complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of bones and joints
- X-rays of the spine and hips
- Bone mineral density test
- Laboratory tests to measure calcium and other minerals in the blood
- Urine tests to measure calcium levels
- CT scan or MRI to assess bone mineral density
- Bone biopsy to check for signs of bone disease
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk of fractures and improve bone health.
- Regular physical activity
- Adequate calcium and vitamin D intake
- Medication to slow bone loss
- Hormone therapy
- Bisphosphonates
- Parathyroid hormone
- Calcitonin
- Denosumab
- Raloxifene
- Strontium Ranelate
No Hospitalization Required
Average Time for Outpatient Care Not Established
Osteoporosis in multiple myelomatosis - Prevention
The best way to prevent osteoporosis in multiple myeloma patients is to ensure adequate calcium and vitamin d intake in the diet, engage in regular physical activity, and take medications such as bisphosphonates or denosumab to reduce the risk of bone loss. additionally, avoiding smoking and excessive alcohol consumption can help reduce the risk of developing osteoporosis in multiple myeloma patients.